Nation's Largest Plastic Surgery Group to Provide Improved Post-Surgical Experience With ON-Q PainBuster.

LAKE FOREST, Calif. -- ON-Q Offered As Post-Surgical Standard of Care for Surgeries Performed at Beverly Hills Surgical Institute

I-Flow Corporation (NASDAQ: IFLO), today announced a strategic relationship with the Beverly Hills Surgical Institute (BHSI), the largest plastic surgery group in the country consisting of 14 of the nation's leading plastic surgeons at their 11 facilities throughout Southern California. BHSI is making ON-Q(R) PainBuster(R) available to its patients undergoing cosmetic/plastic surgeries with the realization that many patients often complain that recovery is worse than the procedure itself. ON-Q offers BHSI patients effective pain relief and the advantage of being able to get back to normal faster.

"Some of our cosmetic surgery clients are concerned about their post-surgical experience because they want to resume their busy, demanding lives as quickly as possible," said Dr. Teresa Ghazoul, Chief of Plastic Surgery of BHSI. "We reviewed the clinical studies that support the use of ON-Q with plastic surgery, and felt that this is an area where we can truly improve our patients' experiences dramatically. We are happy to enhance our practice so that we can make our patients more comfortable in the days and weeks following surgery."

"At BHSI, we are committed to excellence in patient satisfaction," said Lee Mercer, Chief Operating Officer of Beverly Hills Surgical Institute. "With ON-Q, we can provide a virtually pain and nausea-free post-surgical experience and thus we feel that this strategic relationship is another way of accomplishing our goal of exemplary patient care."

More than 2.8 million cosmetic plastic surgery procedures were performed in 2003, up 41 percent from 2002. ON-Q PainBuster is currently used following many cosmetic surgeries including breast augmentation and/or reduction, abdominoplasty (tummy tuck) and some reconstructive surgeries. ON-Q PainBuster recently received enhanced indications for use from the U.S. Food and Drug Administration (FDA) and is now labeled to provide significantly better pain relief than narcotics alone and significantly less need for narcotics after surgery.

"With any elective surgery, patients would like a pain-free recovery and a return to normal as soon as possible and with ON-Q physicians can improve the post-surgical outlook for patients," said Donald M. Earhart, President and CEO of I-Flow Corporation. "Cosmetic surgery is a growing area that is very exciting and we are looking forward to working with the Beverly Hills Plastic Surgery Institute. BHSI is clearly at the forefront of plastic surgery in the markets that they serve and ON-Q is yet another way of improving their surgical outcomes resulting in more satisfied patients."

About ON-Q PainBuster

ON-Q is now labeled to significantly reduce pain and narcotics intake after surgery. ON-Q PainBuster is a simple yet elegant device that consists of a small balloon pump that holds a local anesthetic (a pain-numbing medicine) and delivers it through a tiny, specially designed tube (catheter) directly into the surgical site. The proprietary ON-Q Soaker(TM) Catheter is designed to provide more even distribution of local anesthetic over a wider area, as compared to other catheters, because of its patented wicking capabilities. ON-Q PainBuster delivers narcotic-free pain relief for many surgeries, including: cesarean section, hysterectomy, knee replacement, mastectomy, cardio-vascular/thoracic, foot and ankle and many cosmetic procedures. ON-Q PainBuster helps patients avoid the side effects of narcotics so they can get back to their normal lives faster. Currently, 39 studies on the use of ON-Q have been completed and published and more are underway to demonstrate the benefits of ON-Q in additional areas such as pediatrics and wound healing. For more information about ON-Q, visit www.AskYourSurgeon.com or call 800-448-3569.

About Beverly Hills Surgical Institute

The Beverly Hills Surgical Institute (www.weknowbeauty.com) is a rapidly expanding full service medical group. We take pride in our well maintained, state of the art facilities, multiple convenient locations and the support of a strong team of medical professionals and technicians. Each of our fully accredited Institutes upholds the highest standard of care to ensure safe and pleasant experiences for both our patients and doctors. BHSI is revolutionizing the art of plastic surgery with some of the best Physicians in the business, state-of-the-art facilities at 11 locations throughout Southern California and exceptional Financing.

About I-Flow Corporation

I-Flow Corporation (www.iflo.com) designs, develops and markets technically advanced, low-cost drug delivery systems and services that are redefining the standard of care by providing life-enhancing, cost-effective solutions for pain relief.

Certain disclosures made by the Company in this press release and in other reports and statements released by the Company are and will be forward-looking in nature, such as comments that express the Company's opinions about trends and factors that may impact future operating results. Disclosures that use words such as the Company "believes," "anticipates," or "expects" or use similar expressions are intended to identify forward-looking statements. Forward-looking statements are subject to certain risks and uncertainties, which could cause actual results to differ from those expected, and readers are cautioned not to place undue reliance on these forward-looking statements. The Company undertakes no obligation to republish revised forward-looking statements to reflect the occurrence of unanticipated events. Readers are also urged to carefully review and consider the various disclosures made by the Company in this release, that seek to advise interested parties of the risks, and other factors that affect the Company's business, as well as in the Company's periodic reports on Forms 10-K, 10-Q, and 8-K filed with the Securities and Exchange Commission. The risks affecting the Company's business include, among others: implementation of our direct sales strategy; dependence on our suppliers and distributors; reliance on the success of the home health care industry; our continuing compliance with applicable laws and regulations, such as the Food Drug and Cosmetics Act, and the FDA's concurrence with our management's subjective judgment on compliance issues; the reimbursement system currently in place and future changes to that system; competition in the industry; economic and political conditions in foreign countries; currency exchange rates; inadequacy of booked reserves; technological changes and product availability and acceptance. All such forward-looking statements, whether made in this release or elsewhere, should be considered in context with the various disclosures made by the Company about its business.